Literature DB >> 30652342

Regulation of PTEN/AKT/FAK pathways by PPARγ impacts on fibrosis in diabetic nephropathy.

Rui Yan1, Yuanyuan Wang2, Mingjun Shi2, Ying Xiao2, Lirong Liu3, Lingling Liu2, Bing Guo2.   

Abstract

Renal tubular epithelial-to-mesenchymal transition (EMT) and tubulointerstitial fibrosis (TIF) are important pathological features of diabetic nephropathy (DN). However, the regulatory mechanism underlying EMT and TIF are still unclear. Previous studies showed that the decrease in the expression of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) was closely related to the aggravation of DN, but no published study showed how PTEN participated in the regulation of EMT and TIF. In this study, the rat proximal tubular epithelial cells (NRK52E) and C57BL mice and human kidney tissues were used as the research objects to investigate the mechanism underlying the regulatory effect of peroxisome proliferator-activated receptors γ (PPARγ) on PTEN and its influence on EMT and TIF, the regulation of PTEN's dual activity of lipid phosphatase/protein phosphatase by the serine threonine protein kinase B(AKT)/focal adhesion kinase (FAK) signaling pathway, and the role of PTEN in EMT and TIF. The results showed that PPARγ regulated the expression of PTEN at a transcriptional level and further regulated EMT and TIF. This dual activity could regulate the phosphorylation level of AKT and FAK and also affect FAK transcription. However, the 129 mutant of PTEN (PTEN-G129E) lost the lipid phosphatase activity, and its protein phosphatase activity was involved only in EMT and renal fibrosis through regulating FAK phosphorylation. This study systematically elucidated the role of PPARγ/PTEN/AKT/FAK signaling pathway in EMT and TIF during the pathogenesis of DN.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  diabetic nephropathy; epithelial-to-mesenchymal transition; peroxisome proliferator-activated receptors γ; phosphatase and tensin homolog deleted on chromosome 10; renal tubulointerstitial fibrosis

Year:  2019        PMID: 30652342     DOI: 10.1002/jcb.27937

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

Review 1.  Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis.

Authors:  Xiao-Yuan Liu; Xu-Bin Zhang; Ya-Feng Zhao; Kai Qu; Xiao-Yong Yu
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

2.  Paired‑related homeobox 1 overexpression promotes multidrug resistance via PTEN/PI3K/AKT signaling in MCF‑7 breast cancer cells.

Authors:  Haoyue Luo; Shaobo Cong; Jiaojiao Dong; Litao Jin; Dandan Jiang; Xingang Wang; Qingfeng Chen; Funian Li
Journal:  Mol Med Rep       Date:  2020-08-04       Impact factor: 2.952

3.  Network Pharmacology-Based Prediction of Mechanism of Shenzhuo Formula for Application to DKD.

Authors:  Xinmiao Wang; Haoyu Yang; Lili Zhang; Lin Han; Sha Di; Xiuxiu Wei; Haoran Wu; Haiyu Zhang; Linhua Zhao; Xiaolin Tong
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-17       Impact factor: 2.629

4.  Exploring the Potential Mechanism of Tang-Shen-Ning Decoction against Diabetic Nephropathy Based on the Combination of Network Pharmacology and Experimental Validation.

Authors:  Jiajun Liang; Jiaxin He; Yanbin Gao; Zhiyao Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-09       Impact factor: 2.629

5.  Genetics and Clinical Characteristics of PPARγ Variant-Induced Diabetes in a Chinese Han Population.

Authors:  Siqian Gong; Xueyao Han; Meng Li; Xiaoling Cai; Wei Liu; Yingying Luo; Si-Min Zhang; Lingli Zhou; Yumin Ma; Xiuting Huang; Yufeng Li; Xianghai Zhou; Yu Zhu; Qiuping Wang; Ling Chen; Qian Ren; Ping Zhang; Linong Ji
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-26       Impact factor: 5.555

6.  Gentiopicroside Ameliorates Diabetic Renal Tubulointerstitial Fibrosis via Inhibiting the AT1R/CK2/NF-κB Pathway.

Authors:  Zhanchi Xu; Meng Zhang; Yu Wang; Rui Chen; Shiyue Xu; Xiaohong Sun; Yan Yang; Zeyuan Lin; Shaogui Wang; Heqing Huang
Journal:  Front Pharmacol       Date:  2022-06-23       Impact factor: 5.988

7.  Application of weighted gene co-expression network analysis to identify novel key genes in diabetic nephropathy.

Authors:  Zheng Wang; Xiaolei Chen; Chao Li; Wanxin Tang
Journal:  J Diabetes Investig       Date:  2021-07-30       Impact factor: 4.232

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.